Contact details

Type of addressPostal address
Postal codeYO10 5DD
CountryUnited Kingdom
Address lines
  • Centre for Health Economics
    University of York
    Heslington
    York
    YO10 5DD

Phone: (01904) 321488

Discover related content

Find related publications, people, projects, datasets and more using interactive charts.

View graph of relations

Mr. Paul Revill

Senior Research Fellow

  1. A Cost and Outcomes Analysis of Models of Care for Severely Disabled Young Children in Ireland

    Normand, C. & Revill, P., 2010, Ireland: Jack and Jill Foundation.

    Research output: Book/ReportCommissioned report

  2. An Assessment of the Particular Vulnerability of HIV/AIDS Treatment Programmes to Interruptions in Funding (A Case Study of Malawi)

    Revill, P., Lahiff, E., Ryan, P., Outram, V., Nkhoma, D. & Basarir, H., 2010, World Bank/UNAIDS HIV/AIDS Economics Reference Group.

    Research output: Book/ReportCommissioned report

  3. Antiretroviral therapy recommendations for the global community: aspiration versus reality

    Phillips, A. N., Munderi, P., Revill, P. A., El-Sadr, W. M. & Lundgren, J. D., 27 Dec 2013

    Article in Aids

  4. Assessment of the Potential Impact and Cost-effectiveness of Self-Testing for HIV in Low-Income Countries

    Cambiano, V., Ford, D., Mabugu, T., Napierala Mavedzenge, S., Miners, A., Mugurungi, O., Nakagawa, F., Revill, P. & Phillips, A., 2015

    Article in The Journal of Infectious Diseases

  5. Confronting Tight Fiscal, Human Resource, and Evidence Constraints, Malawi Revises Its Benefits Package

    Manthalu, G., Nkhoma, D., Ochalek, J. M., Phillips, A. & Revill, P., 10 Oct 2017, What's In, What's Out: Designing Benefits for Universal Health Coverage. Glassman, A., Giedion, U. & Smith, P. C. (eds.). Washington D.C.: Center for Global Development

    Research output: Chapter in Book/Report/Conference proceedingChapter

  6. Cost effectiveness of potential ART adherence monitoring interventions in sub-saharan Africa

    Phillips, A. N., Cambiano, V., Nakagawa, F., Bansi-Matharu, L., Sow, P. S., Ehrenkranz, P., Ford, D., Mugurungi, O., Apollo, T., Murungu, J., Bangsberg, D. R. & Revill, P., 15 Dec 2016

    Article in PLoS ONE

  7. Cost-Effectiveness of HIV Drug Resistance Testing to Inform Switching to Second Line Antiretroviral Therapy in Low Income Settings

    Phillips, A., Cambiano, V., Nakagawa, F., Magubu, T., Miners, A., Ford, D., Pillay, D., De Luca, A., Lundgren, J. & Revill, P., 7 Oct 2014

    Article in PLoS ONE

  8. Cost-effectiveness of different strategies to monitor adults on antiretroviral therapy: a combined analysis of three mathematical models

    Keebler, D., Revill, P., Braithwaite, S., Phillips, A., Blaser, N., Borquez, A., Cambiano, V., Ciaranello, A., Estill, J., Gray, R., Hill, A., Keiser, O., Kessler, J., Menzies, N. A., Nucifora, K. A., Salazar Vizcaya, L., Walker, S. M., Welte, A., Easterbrook, P., Doherty, M. & 2 othersHirnschall, G. & Hallett, T. B., Jan 2014

    Article in Lancet Global Health

  9. Cost-effectiveness of public-health policy options in the presence of pretreatment NNRTI drug resistance in sub-Saharan Africa: a modelling study

    Phillips, A. N., Cambiano, V., Nakagawa, F., Revill, P., Jordan, M. R., Hallett, T. B., Doherty, M., De Luca, A., Lundgren, J. D., Mhangara, M., Apollo, T., Mellors, J., Nichols, B., Parikh, U., Pillay, D., Rinke de Wit, T., Sigaloff, K., Havlir, D., Kuritzkes, D. R., Pozniak, A. & 6 othersvan de Vijver, D., Vitoria, M., Wainberg, M. A., Raizes, E., Bertagnolio, S. & Working Group on Modelling Potential Responses to High Levels of Pre-ART Drug Resistance in Sub-Saharan Africa, 22 Nov 2017

    Article in Lancet HIV

  10. Cost-effectiveness thresholds: guiding health care spending for population health improvement

    Revill, P., Ochalek, J. M., Lomas, J. R. S., Nakamura, R., Woods, B. S., Rollinger, A., Suhrcke, M. E., Sculpher, M. J. & Claxton, K. P., Nov 2015, The International Decision Support Initiative.

    Research output: Book/ReportCommissioned report

  11. Country-level cost-effectiveness thresholds: initial estimates and the need for further research.

    Woods, B., Revill, P., Sculpher, M. & Claxton, K. P., Mar 2015, York, UK: Centre for Health Economics, University of York, p. 1-24, 24 p. (CHE Research Paper; no. 109).

    Research output: Working paperDiscussion paper

  12. Decision rules for cost-effectiveness analysis in low- and middle-income countries: Panel

    Faria, R., Revill, P., Glassman, A., Kingkaew, P., Mejía, A. & Wilkinson, T., 2014, (Unpublished).

    Research output: Contribution to conferenceOther

  13. Decision rules in economic evaluation of healthcare interventions

    Faria, R. & Revill, P., Aug 2014, Guidelines for the economic evaluation of healthcare technologies in Colombia: technical support documents. Bogota: Instituto de Evaluación Tecnológica en Salud, p. 42-52

    Research output: Chapter in Book/Report/Conference proceedingChapter

  14. Economic Evaluation of Healthcare Programs and Interventions: Applications to Low- and Middle-Income Countries

    Revill, P., Woods, B. & Sculpher, M., 2015, World Scientific Handbook of Global Health Economics and Public Policy. Scheffler, R. M. (ed.). World Scientific Publishing, Vol. 1.

    Research output: Chapter in Book/Report/Conference proceedingChapter

  15. Economic analysis of vaccination programs

    Mauskopf, J., Standaert, B., Connolly, M. P., Culyer, A. J., Garrison, L. P., Hutubessy, R., Jit, M., Pitman, R., Revill, P. & Severens, J. L., 1 Oct 2018

    Article in Value in Health

Previous 1 2 3 4 Next